Non-ownership Filings
| Notice of Results | Sep. 16, 2025 |
| Submission of new Phase III study protocol to FDA | Aug. 12, 2025 |
| Block Listing Six Monthly Return | Jul. 24, 2025 |
| Promotion & sales representative agreement | Jun. 24, 2025 |
| Result of AGM | Jun. 09, 2025 |
| FDA expands XENOVIEW indication | Jun. 02, 2025 |
| Dr. Bastiaan Driehuys awarded by ATS | May. 21, 2025 |
Ownership Update Filings
| Holding(s) in Company | Sep. 11, 2025 |
| Holding(s) in Company | May. 06, 2025 |
| Holding(s) in Company | Dec. 11, 2024 |
| Repricing of Options and Grant of Options | Jul. 29, 2024 |
| PDMR Dealing | Jul. 18, 2024 |
| Holding(s) in Company | Jun. 19, 2024 |
| Holding(s) in Company | Jun. 19, 2024 |